News and media

Morag Millington | 25/11/2020

The Board of MND Australia is delighted to announce the appointment of David Ali as its new Chief Executive Officer.

Morag Millington | 24/11/2020

We are pleased to announce that our research arm, MND Research Australia, has awarded close to $3 million in grants for MND research commencing in 2021.

Morag Millington | 3/11/2020

MEDIA RELEASE

Morag Millington | 30/10/2020

We were delighted to learn this week that an early feasibility study of the Stentrode brain implant has successfully shown that it can aid people living with paralysis, such as those with MND, to continue to maintain communication. MND Research Australia funded early research into development of this device. 

Morag Millington | 13/10/2020

While MND Australia welcomes the much needed investments in aged care, health, disability & research handed down in the Budget, we believe that significant further funding is still required in these sectors. 

Carol Birks | 8/10/2020

A recent publication by MNDRA-funded Melbourne researchers has identified an immune pathway that may play a key role in the neuroinflammation seen in MND and present a novel target for developing new treatments.

They found that by blocking an immune sensor called STING, they could dramatically prevent inflammation from MND patient cells, paving the way for a new class of drugs to be developed for people with neurodegenerative disorders, such as MND.

Laura Birks | 23/09/2020

The September edition of MND Australia's International Research Update is now available. 

Morag Millington | 3/09/2020

We welcome the publication today of results from the CENTAUR stage 2 clinical trial of AMX0035 (Tauroursodeoxycholic Acid and Sodium Phenylbutyrate) for the treatment of MND/ALS progression.

Morag Millington | 28/08/2020

MEDIA RELEASE

Morag Millington | 6/07/2020

Applications for MND Research Australia's 2021 grants are now open.